TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

NCT07189195 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
Metastatic Pancreatic Adenocarcinoma
Refractory Pancreatic Adenocarcinoma
Stage III Pancreatic Cancer AJCC v8
Stage IV Pancreatic Cancer AJCC v8
Unresectable Malignant Solid Neoplasm
Unresectable Pancreatic Adenocarcinoma

Interventions

DRUG: TR-002

Sponsor

University of California, Davis

Collaborators

[object Object]